Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP941008.RAB9TQ7W0bf2qJ2xpT18Zr4lLBaVw0_duU0kKw_HJs-DE130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP941008.RAB9TQ7W0bf2qJ2xpT18Zr4lLBaVw0_duU0kKw_HJs-DE130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP941008.RAB9TQ7W0bf2qJ2xpT18Zr4lLBaVw0_duU0kKw_HJs-DE130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP941008.RAB9TQ7W0bf2qJ2xpT18Zr4lLBaVw0_duU0kKw_HJs-DE130_provenance.
- NP941008.RAB9TQ7W0bf2qJ2xpT18Zr4lLBaVw0_duU0kKw_HJs-DE130_assertion description "[Immunohistochemical expression of topoisomerase IIalpha (Topo IIalpha) and multidrug resistance-associated protein (MRP), plus chemosensitivity testing, as chemotherapeutic indices of ovarian and endometrial carcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP941008.RAB9TQ7W0bf2qJ2xpT18Zr4lLBaVw0_duU0kKw_HJs-DE130_provenance.
- NP941008.RAB9TQ7W0bf2qJ2xpT18Zr4lLBaVw0_duU0kKw_HJs-DE130_assertion evidence source_evidence_literature NP941008.RAB9TQ7W0bf2qJ2xpT18Zr4lLBaVw0_duU0kKw_HJs-DE130_provenance.
- NP941008.RAB9TQ7W0bf2qJ2xpT18Zr4lLBaVw0_duU0kKw_HJs-DE130_assertion SIO_000772 11712788 NP941008.RAB9TQ7W0bf2qJ2xpT18Zr4lLBaVw0_duU0kKw_HJs-DE130_provenance.
- NP941008.RAB9TQ7W0bf2qJ2xpT18Zr4lLBaVw0_duU0kKw_HJs-DE130_assertion wasDerivedFrom befree-20150227 NP941008.RAB9TQ7W0bf2qJ2xpT18Zr4lLBaVw0_duU0kKw_HJs-DE130_provenance.
- NP941008.RAB9TQ7W0bf2qJ2xpT18Zr4lLBaVw0_duU0kKw_HJs-DE130_assertion wasGeneratedBy ECO_0000203 NP941008.RAB9TQ7W0bf2qJ2xpT18Zr4lLBaVw0_duU0kKw_HJs-DE130_provenance.
- befree-20150227 importedOn "2015-02-27" NP941008.RAB9TQ7W0bf2qJ2xpT18Zr4lLBaVw0_duU0kKw_HJs-DE130_provenance.